Bevacizumab in the treatment of idiopathic macular telangiectasia

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 8, 2008, Pages 1189-1193

  Gamulescu, Maria Andreea ^a   Walter, Andreas ^a   Sachs, Helmut ^a   Helbig, Horst ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Avastin ; Bevacizumab; Idiopathic juxtafoveal retinal telangiectasia; Idiopathic macular telangiectasia; Treatment

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; IDIOPATHIC MACULAR TELANGIECTASIA; LONG TERM CARE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REMISSION; RETINA MACULA CYSTOID EDEMA; RETINA MACULOPATHY; RETROSPECTIVE STUDY; TREATMENT DURATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL DISEASES; RETINAL VESSELS; RETROSPECTIVE STUDIES; TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 46949097884     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0795-6     Document Type: Article

References (14)

1. Gass JDM (1968) A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis. Arch Ophthalmol 80:592-605
2. Gass JDM, Blodi BA (1993) Idiopathic juxtafoveolar retinal telangiectasis: Update of classification and follow-up study. Ophthalmology 100:1536-1546
3. Yannuzzi LA, Bardal AMC, Freund KB, Chen KJ, Eandi CM, Blodi B (2006) Idiopathic macular telangiectasia. Arch Ophthalmol 124(4):450-460
4. Paunescu LA, Ko TH, Duker JS, Chan A, Drexler W, Schuman JS, Fujimoto JG (2006) Idiopathic juxtafoveal retinal telangiectasis: New findings by ultrahigh-resolution optical coherence tomography. Ophthalmology 113(1):48-57
5. Surguch V, Gamulescu MA, Gabel VP (2007) Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 245(6):783-788
6. Potter MJ, Szabo SM, Chan EY, Morris AH (2002) Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 133(1):149-151
7. Lynch SS, Cheng CM (2007) Bevacizumab for neovascular ocular diseases. Ann Pharmacother 41(4):614-625
8. Chew EY (2006) Parafoveal telangiectasis. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson CP (eds) Retina 4th ed. Vol. 2. Mosby, St. Louis, pp 1409-1415
9. Park DW, Schatz H, McDonald HR, Johnson RN (1997) Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 104(11):1838-1846
10. Alldredge CD, Garretson BR (2003) Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 23(1):113-116
11. Li KK, Goh TY, Parsons H, Chan WM, Lam DS (2005) Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis. Clin Experiment Ophthalmol 33(5):542-544
12. Moon SJ, Berger AS, Tolentino MJ, Misch DM (2007) Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surg Lasers Imaging 38(2):164-166
13. Schulze S, Mennel S (2007) Behandlung idiopathischer juxtafoveolärer retinaler Teleangiektasien mit Bevacizumab (Avastin). Klin Monatsbl Augenheilkd 224:787-790
14. Charbel Issa P, Holz FG, Scholl HPN (2007) Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 114:1736-1742